Inovio PharmaceuticalsINO
那斯達克 · USD
1.43
+0.01
(+0.70%)
盤中 08/02 12:56 (UTC+8)
08/02 12:56 (UTC+8)
Inovio PharmaceuticalsINO
1.43
+0.01
(+0.70%)
財務數據
損益表
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- -
- 0.00
- -
- 0.00
- 0.00
- -98.63
- -8.00
- 96.52
- 71.68
- -73.45
- -
- -
- -
- -
- -44.44
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 65 | 117 | - | 101 | - | 103 | 388 | 226 | 115 | 125 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 65 | 117 | - | 101 | - | 103 | 388 | 226 | 115 | 125 |
營業費用 | 25,116 | 20,486 | 27,348 | 33,298 | 31,485 | 27,496 | 35,941 | 37,267 | 44,068 | 56,071 |
研發費用 | 16,091 | 12,885 | 18,734 | 23,088 | 20,914 | 17,253 | 15,503 | 23,744 | 30,177 | 42,120 |
推銷及管理費用 | 9,025 | 7,601 | 8,614 | 10,210 | 10,571 | 10,243 | 9,925 | 13,523 | 13,891 | 13,951 |
非經常性項目費用 | - | - | - | - | - | - | 10,513 | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -25,051 | -20,370 | -27,347 | -33,197 | -31,485 | -27,394 | -35,553 | -37,041 | -43,952 | -55,946 |
其他收入及費用 | 4,520 | 1,752 | 527 | 1,315 | 818 | 958 | 1,942 | 740 | -219 | -876 |
利息費用 | - | - | - | - | 178 | 282 | 313 | 313 | 313 | 313 |
稅前純益 | -20,530 | -18,618 | -26,821 | -31,882 | -30,845 | -26,718 | -33,925 | -36,614 | -44,484 | -57,135 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -19,695 | -19,382 | -25,165 | -32,237 | -30,470 | -25,004 | -33,930 | -35,535 | -40,649 | -54,463 |
基本每股稅後盈餘(元) | -0.51 | -0.56 | -0.89 | -1.19 | -1.31 | - | -0.13 | -0.13 | -0.16 | -0.02 |
稀釋每股稅後盈餘(元) | -0.51 | -0.60 | -0.87 | -1.17 | -1.31 | -0.09 | -0.13 | -0.13 | -0.16 | -0.21 |
基本平均股數(千股) | 38613.00 | 30015.00 | 28140.00 | 27197.00 | 23291.00 | - | 268623.00 | 264354.00 | 258438.00 | 3007026.00 |
稀釋平均股數(千股) | 38613.00 | 30015.00 | 28140.00 | 27197.00 | 23291.00 | - | 268623.00 | 264354.00 | 258438.00 | 3007026.00 |
還原基本每股稅後盈餘(元) | -0.51 | -0.56 | -0.89 | -1.19 | -1.31 | - | -1.52 | -1.61 | -1.89 | -0.21 |
還原稀釋每股稅後盈餘(元) | -0.51 | -0.60 | -0.87 | -1.17 | -1.31 | -1.08 | -1.51 | -1.61 | -1.89 | -2.55 |
還原基本平均股數(千股) | 38,613 | 30,015 | 28,140 | 27,197 | 23,291 | - | 22,385 | 22,029 | 21,536 | 250,584 |
還原稀釋平均股數(千股) | 38,613 | 30,015 | 28,140 | 27,197 | 23,291 | - | 22,385 | 22,029 | 21,536 | 250,584 |
EBITDA(千元) | -18,952 | -18,786 | -24,755 | -31,879 | -30,217 | -25,591 | -33,824 | -35,322 | -40,343 | -53,537 |